Anavex Life Sciences Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$2.47

+0.07 (+2.92%)

As of Sep 22, 3:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,108.5% upside

Low Target $17.55

Average Target $29.85

High Target $40.51

Current Price $2.47

Current
$2.47

Target
$29.85

$17.55 $29.85 avg $40.51

Scenario Analysis

Bear Case

$17.55

610.5%

Low target

Base Case

$29.85

+1,108.5%

Avg target

Bull Case

$40.51

+1,540.1%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$10.38

-76.2% from high

52-Week Low

$2.26

+9.5% from low

Target vs 52W High

$29.85

+187.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%